# Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids

> **NCT04426734** · PHASE4 · UNKNOWN · sponsor: **New England Retina Associates** · enrollment: 30 (estimated)

## Conditions studied

- Non-infectious Anterior Uveitis

## Interventions

- **DEVICE:** Dextenza Dexamethasone Implant
- **DRUG:** Topical Prednisolone Acetate 1%

## Key facts

- **NCT ID:** NCT04426734
- **Lead sponsor:** New England Retina Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04426734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04426734, "Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04426734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*